Project Grant R03HL173142
Award Date
5/1/24
Completion Date
4/30/26
Dollars Obligated
$351K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This Project Grant award of $194,400 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development of a multilevel implementation intervention to improve equitable prescription of evidence-based heart failure therapies. The award aims to: 1) assess variation in guideline-directed medical therapy (GDMT) prescribing during heart failure admissions, 2) identify determinants to promote equitable GDMT implementation, and 3) design...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Program (CFDA 93.837), will provide $198,936 to New York University School of Medicine to investigate the impact of restrictive drug coverage policies on heart failure care. The key products and services to be delivered through this 5-year grant include: Quantifying the effects of restrictive drug coverage policies, such as cost-sharing and prior authorization...
This Project Grant award of $590,371 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to identify successful strategies for implementing specialist palliative care for people with advanced heart failure. The primary objectives are to determine the key modifiable structures and processes of specialist palliative care delivery that increase the reach and improve end-of-life care quality for this patient population. The...
This $1,314,026 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support a multi-center clinical trial to evaluate the safety and probable benefit of the Selective Cytopheretic Device (SCD) as a bridge to left ventricular assist device (LVAD) implantation for chronic heart failure (CHF) patients. The SCD is an immunomodulatory, extracorporeal device designed to dampen the cardio-depressant...
This federal Project Grant award, valued at $971,652.00 and awarded by the National Institute of Nursing Research (NINR) under the Nursing Research program (CFDA 93.361), supports research on patient activation, cognition, and self-management for patients with left-ventricular assist devices (LVADs). The primary objectives are to examine the relationships between patient activation, cognition, LVAD self-management behaviors, and healthcare utilization. This observational study will recruit...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), supports a 5-year research study titled "Evaluating Policies to Improve Heart Failure Outcomes in Medicare" under the Cardiovascular Diseases Research program (CFDA 93.837). The $169,416 award to Beth Israel Deaconess Medical Center will evaluate the impact of Medicare Advantage plans and the Inflation Reduction Act on healthcare access, affordability,...
This $161,175 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support a multi-year research study led by Dr. Jonathan Edelson at The Children's Hospital of Philadelphia (CHOP). The overarching goal is to develop a better understanding of the environmental determinants of physical activity in pediatric heart transplant patients, a population at high risk of cardiovascular complications. The...
This $777,674 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) will fund research to build the largest echocardiography registry in the world and generate comparative effectiveness evidence for guideline-directed medical therapies in heart failure patients with mid-range ejection fraction. The key objectives are to aggregate echocardiography data from 11 hospitals, test statistical...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), has awarded a $789,026 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to evaluate the long-term effectiveness and value of cardiac rehabilitation (CR) in diverse populations. The key products and services to be delivered under this 4-year project include: Leveraging large, linked datasets and novel causal...
This federal Project Grant award, valued at $1,399,182.00 and awarded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) on August 1, 2024, supports a comprehensive research study to investigate early-life risk factors and underlying mechanisms for the development of adult coronary heart disease (CHD). The primary objectives are to: 1) identify which small-for-gestational-age (SGA) infants are at elevated risk for later-life CHD and cardiovascular...